Trials / Completed
CompletedNCT00557336
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
Evaluation of Efficacy and Safety of Somatropin in SGA Children Due to IUGR
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 2 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. The aim of this clinical trial is to evaluate the height gain during 12 months of growth hormone treatment in children born small for gestational age due to intrauterine growth retardation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2003-07-28
- Primary completion
- 2005-06-29
- Completion
- 2005-06-29
- First posted
- 2007-11-14
- Last updated
- 2017-02-28
Locations
37 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00557336. Inclusion in this directory is not an endorsement.